Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 71 Results Clear All
Scientists develop powerful drug candidates that could head off future coronavirus pandemics.
News Release Research (Publication) COVID-19 Virology Krogan Lab Ott Lab
Scientists at Gladstone and UCSF discover how one protein controls the behavior of immune cells, with potential applications for treating cancer and autoimmune conditions.
News Release Research (Publication) Autoimmune Diseases Cancer Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
The featured scientists include global leaders in gene editing, systems biology, AI, and immunology.
Awards News Release Doudna Lab Krogan Lab Marson Lab Pollard Lab Ye Lab
Cell Press—Gladstone Investigator Nevan Krogan, who was selected as one of the Cell Press 50 Scientists that Inspire, discusses how new technologies can break down barriers in research and reveal more commonalities across different disease areas than currently known.
Gladstone Experts Krogan Lab
KCBS Radio—Diagnoses of autism spectrum disorder, or ASD, have been rising over the past decades, with one in 36 children identified with the condition in 2020 compared to one in 150 back in 2000, according to the US Centers for Disease Control and Prevention. Nevan Krogan, PhD, senior investigator at Gladstone Institutes and director of the Quantitative Biosciences Institute at UC San Francisco, shares new research on genetic changes that contribute to ASD.
Gladstone Experts Research (Publication) Neurological Disease Krogan Lab
A Q&A with researchers Bruce Conklin and Juan Perez-Bermejo
Research (Publication) Mass Spectrometry Facility Heart Failure Data Science and Biotechnology Conklin Lab Krogan Lab Stem Cells/iPSCs
New research into how blood makes the brain’s immune cells toxic points to new treatments for Alzheimer’s disease and multiple sclerosis
News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab Krogan Lab Pico
Gladstone investigator is awarded the Legion of Honor
Awards Krogan Lab
UCSF News—Nevan Krogan, PhD, a senior investigator at Gladstone and the director of the Quantitative Biosciences Institute at UC San Francisco, leads a vast, international collaborative effort to find drugs against COVID-19 called the QBI Coronavirus Research Group (QCRG). The group recently received $67.5 million from the National Institutes of Health, the largest such award in UCSF's history, to pursue work on coronaviruses and other viruses with pandemic potential.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
A new catalog to help better understand how HIV hijacks human cells
Research (Publication) HIV/AIDS Data Science and Biotechnology Genomic Immunology Virology Krogan Lab Marson Lab
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
abc7 News—Senior Investigators Warner Greene, MD, PhD, and Nevan Krogan, PhD, discuss the possibility that Omicron, although more transmissible than previous SARS-CoV-2 variants, may cause less severe disease.
Gladstone Experts COVID-19 Center for HIV Cure Research Data Science and Biotechnology Virology Greene Lab Krogan Lab
ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab
While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly
Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab
